Home / Brands / Osmotica Pharmaceutical
Osmotica Pharmaceutical Recalls
4 recalls on record · October 9, 2013 to March 14, 2018 · Drugs
Recalls by year
13
17
18
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
March 14, 2018DrugsFDA
Osmotica Pharmaceutical Corp recalls Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC
Hazard: Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.
December 27, 2017DrugsFDA
Osmotica Pharmaceutical Corp recalls Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC.
Hazard: Subpotent Drug
December 27, 2017DrugsFDA
Osmotica Pharmaceutical Corp recalls Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC
Hazard: Subpotent Drug
October 9, 2013DrugsFDA
Osmotica Pharmaceutical Corp recalls Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count bottle (NDC 0131-3268
Hazard: Failed Dissolution Specification:12 hour time point at 18 months of product shelf life.